OakChart

INVO Fertility Inc

IVFHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 2:43 PM ET

2.57+0.07 (2.60%)
2026-11-11 20:46 CET
Market cap
2.98 USD m
Revenue, TTM
7.53 USD m
Net income, TTM
-5.88 USD m
Free cash flow, TTM
-4.81 USD m
EPS diluted, TTM
-123.06
P/E
-
Compare

Price

IVF against its 20, 50 and 200-day averages
2050200beatearnings
0.0020.0040.0060.0080.0015.0M30.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IVFclose 2.5720-day 2.2250-day 3.03200-day 8.032.57

97.4% under the 52-week high of 98.00 on 12 Nov 2025. 52-week low 1.59 on 30 Oct 2026. Last 15 sessions, 70.6% high to low

Profile

IVF
52-week range, 1% of the way up
1.5998.00

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.

Employees42
IPONov 11, 2008
Beta2.36
ATR, 14d0.30
Rel volume0.03
Short float0.68%
Inst own5.19%

Snapshot

6 groups

Valuation

Index-
Market Cap3.06M
Enterprise Value3.65M
Income-5.88M
Sales7.53M
Book/sh28.05
Cash/sh3.13
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees42
IPONov 11, 2008

Ratios

P/E-
Forward P/E-
PEG-
P/S0.41
P/B0.09
P/C0.82
P/FCF-
EV/EBITDA-
EV/Sales0.48
Quick Ratio0.67
Current Ratio0.71
Debt/Eq0.24
LT Debt/Eq0.14
Option/ShortNo / Yes

Earnings

EPS (ttm)-123.06
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y86.33% 72.72%
Sales past 3/5Y102.64% 45.83%
EPS Y/Y TTM99.18%
Sales Y/Y TTM13.76%
EPS Q/Q100.09%
Sales Q/Q16.73%
EarningsAug 17 BMO
EPS/Sales Surpr.- -

Ownership

Insider Own-
Insider Trans-
Inst Own5.19%
Inst Trans-
ROA-26.06%
ROE-61.53%
ROIC-31.16%
Gross Margin27.82%
Oper. Margin-78.72%
Profit Margin-78.11%
SMA2015.45%
SMA50-15.31%
SMA200-68.08%
Trades-

Technical

Shs Outstand1.19M
Shs Float1.12M
Short Float0.68%
Short Ratio0.01
Short Interest0.01M
52W High98.00 -97.38%
52W Low1.59 61.32%
Volatility15.05% 15.22%
ATR (14)0.30
RSI (14)52.23
Beta2.36
Rel Volume0.03
Avg Volume535.16K
Volume15,250

Performance

Perf Week25.12%
Perf Month0.21%
Perf Quarter-33.90%
Perf Half Y-59.29%
Perf YTD-82.96%
Perf Year-97.05%
Perf 3Y-99.97%
Perf 5Y-100.00%
Perf 10Y-100.00%
Recom1.00
Target Price80.00
Prev Close2.50
Price2.57
Change %2.60%

Peers

Mkt cap
TickerCompanyMkt cap
NIVFNewGenIvf Group Ltd0.37M
FEMYFemasys Inc12.57M
PGNYProgyny Inc2.68B
CCELCryo-Cell International Inc40.32M
AIRSAirsculpt Technologies Inc61.98M
BTMDbiote Corp62.73M
MNDRMobile health Network Solutions1.17M
JYNTJoint Corp94.73M
PARKPark Dental Partners Inc104.83M
BMGLBasel Medical Group Ltd9.03M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Szot Matthew KDirectorDec 03 '25Sale1.52463Dec 05 09:40 PM

News

latest 14 of 200
  • INVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable (GlobeNewswire)
  • INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026 (GlobeNewswire) +8.09% -9.74%
  • INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference (GlobeNewswire)
  • INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference (GlobeNewswire)
  • INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International (GlobeNewswire)
  • INVO Fertility Inc (IVF) (Q2 2026) Earnings Call Highlights: Revenue Surges 17% as Clinic-Level ... (GuruFocus.com) +57.47% -6.54%
  • INVO Fertility Q2 Revenue Rises 17% as Clinic-Level Profitability Improves (InvestorsHub)
  • INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability (GlobeNewswire)
  • SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today (Stocktwits) -6.06% +97.58%
  • INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure (GlobeNewswire) -7.33%
  • INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) +11.84%
  • INVO Fertility Announces Fiscal Year 2025 Financial Results (GlobeNewswire)
  • INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
  • INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026 (GlobeNewswire) -6.21%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-171.400-1.4002.18--
2026Q12026-06-22-13.520--13.5281.58--
2025Q42026-06-028,083-11.00011.8351.581.931
2025Q32025-11-17-123.2--122.731.76--
2025Q22025-08-14-2,128--1,5101.861.68-
2025Q12025-05-20-6,014-288-6,0141.641.611
2024Q42025-04-30-4,339-1,680-5,0731.691.501
2024Q32024-11-11-2,419--2,4171.43--
2024Q22024-08-14-3,571--3,5821.84--
2024Q12024-05-15---2,4191.58--
2023Q42024-04-1614,354--4,6103.52--
2023Q32023-11-13-3,237-5,702-4,0471.351.001
2023Q22023-08-14-17,626-24,192-17,6240.710.451
2023Q12023-05-15-23,040-18,432-23,6030.650.371
2022Q42023-04-17-26,496-21,888-26,1960.280.261
2022Q32022-11-14-24,192-13,824-24,1630.450.201

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-175,104-113,472-175,1651.041.28
2021FY-72,576-100,800-72,1054.161.30
2022FY-103,680-97,920-103,5110.820.80
2023FY-29,549--32,3376.23-
2024FY-14,491-7,440-12,7146.536.35
2025FY-858.56-594.2-6.847.19
2026FY--11.600--10.42
2027FY--4.000--16.46
2028FY-1.400--26.01
2029FY-5.000--39.01
2030FY-8.600--52.67

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-02-091002.712.712.71
2026Q3R2026-02-09100-2.60-2.60-2.60
2026Q3E2026-02-09100-2.60-2.60-2.60
2026Q2S2026-02-091002.402.402.40
2026Q2S2025-07-301001.841.841.84
2026Q2S2025-07-291001.841.841.84
2026Q2S2025-07-281001.841.841.84
2026Q2S2025-07-271001.841.841.84
2026Q2S2025-07-261001.841.841.84
2026Q2S2025-07-251001.841.841.84
2026Q2S2025-07-241001.841.841.84
2026Q2S2025-07-231001.841.841.84
2026Q2S2025-07-221001.841.841.84
2026Q2S2025-07-211001.841.841.84

Estimate history

EPS, annual-18321.408-76972.033-51425.281-175165.056-72104.832-103510.656-32336.64-12713.702-264.452-123.0558
Period201720182019202020212022202320242025TTM
EPS, quarterly-3582.49-2417.069-5072.717-6013.589-1509.797-122.73411.835-13.5281.372
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.2820.4941.481.0374.160.8223.0216.5326.8417.53
Period201720182019202020212022202320242025TTM
Sales, quarterly1.8371.4331.6861.6371.8641.7571.5832.0152.175
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual00000000.0010.1190.574
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.0010.0010.0010.0020.0010.0340.1190.410.574
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue7.536.846.533.020.824.161.041.480.49
Cost of Goods Sold Incl. D&A5.444.994.582.140.590.290.090.140.09
Gross Profit2.101.851.950.890.233.870.951.340.40
Selling, General and Administrative Excl. Other8.027.698.077.6510.869.086.463.133.04
Research and Development-0.000.000.170.540.220.40--
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-5.93-5.84-6.12-6.77-10.63-5.22-5.51-1.79-2.63
Interest Expense1.131.301.040.930.061.272.840.380.44
Unusual Expense-1.49-1.62-0.050.250.000.170.00-0.00
Net Income Before Taxes-5.38-5.49-7.60-8.01-10.89-6.65-8.35-2.17-3.08
Income Taxes0.500.450.140.030.000.000.000.000.00
Consolidated Net Income-5.88-5.93-7.74-8.03-10.89-6.65-8.35-2.17-3.08
Net Income From Continuing Operations-5.88-5.93-7.74-8.03-10.89-6.65-8.35-2.17-3.08
Net Income-5.88-7.74-7.99-8.03-10.89-6.65-8.35-2.17-3.08
EPS (Recurring)-10.69-303.30-12,773.89-31,623.68-103,510.53-70,827.58-175,165.14-51,433.02-76,966.45
EPS (Basic, Before Extraordinaries)-122.74-264.45-12,713.70-32,336.64-103,510.66-72,104.83-175,165.06-51,425.28-76,972.03
EPS (Diluted)-123.06-264.45-12,713.70-32,336.64-103,510.66-72,104.83-175,165.06-51,425.28-76,972.03
EBITDA-5.37-5.16-5.20-6.57-10.32-5.05-5.48-1.76-2.63
Non-Operating Income (Expense)0.190.03-0.50-0.06-0.200.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.250.140.000.041.661.901.610.07-
Price To Sales Ratio0.650.060.450.646.258.5115.9322.69125.17
Gross Margin27.8227.0629.9229.3127.8592.9791.4490.5681.72
Operating Margin-78.72-85.36-93.63-224.04-1,292.45-125.39-531.67-120.80-532.81
Net Margin-78.11-113.15-122.33-266.00-1,324.81-159.97-804.73-146.43-622.22
Shares Outstanding0.570.120.000.000.000.000.000.000.00
Market Capitalization2.982.983.633.345.1639.7229.0133.8064.80

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue2.182.021.581.761.861.641.691.43
Cost of Goods Sold Incl. D&A1.561.431.181.261.261.281.191.22
Gross Profit0.620.590.400.490.600.360.500.21
Selling, General and Administrative Excl. Other1.912.181.812.132.192.823.961.51
Research and Development--0.000.000.000.270.480.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.29-1.59-1.41-1.64-1.59-2.46-3.46-1.30
Interest Expense0.180.180.630.150.220.310.230.27
Unusual Expense-2.283.79-3.880.881.3814.650.000.00
Net Income Before Taxes0.94-5.541.86-2.64-3.21-17.40-3.68-1.60
Income Taxes0.060.000.450.000.000.00-0.050.03
Consolidated Net Income0.89-5.541.41-2.64-3.21-17.40-3.62-1.63
Net Income From Continuing Operations0.89-5.541.41-2.64-3.21-17.40-3.62-1.63
Net Income0.89-5.541.41-2.64-3.75-17.40-3.87-1.63
EPS (Recurring)-1.09-7.05-10.90-94.27-1,122.28-2,471.30-5,072.73-2,417.05
EPS (Basic, Before Extraordinaries)1.69-13.5311.84-122.73-1,509.80-6,013.59-5,072.72-2,417.07
EPS (Diluted)1.37-13.5311.84-122.73-1,509.80-6,013.59-5,072.72-2,417.07
EBITDA-1.14-1.45-1.28-1.50-1.42-2.23-3.23-1.07
Non-Operating Income (Expense)0.130.020.020.01-0.020.020.02-0.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.070.090.070.010.070.07-0.05
Price To Sales Ratio0.650.620.260.380.160.420.550.44
Gross Margin28.3729.0425.2928.0432.2121.8529.4614.95
Operating Margin-59.28-78.95-89.20-93.08-85.46-150.40-205.47-90.74
Net Margin40.85-274.8889.21-150.51-201.24-1,063.02-229.79-113.78
Shares Outstanding0.570.410.120.030.000.000.000.00
Market Capitalization2.984.461.804.120.241.493.632.77

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2.080.620.230.095.6810.101.240.210.03
Short Term Receivables0.220.110.140.080.050.020.010.230.09
Inventories0.230.220.260.260.290.270.100.040.06
Other Current Assets0.240.300.620.190.280.160.200.250.06
Total Current Assets2.761.261.260.626.3110.541.540.730.23
Net Property, Plant & Equipment1.671.964.192.242.540.210.190.030.02
Total Investments and Advances2.470.003.091.241.490.100.000.000.00
Long-Term Note Receivable6.121.22-------
Intangible Assets7.209.159.970.000.130.090.060.010.02
Other Assets0.0032.480.000.000.000.000.000.000.00
Total Assets20.2246.0818.514.1010.4710.951.800.780.27
Short Term Debt Incl. Current Port. of LT Debt1.486.231.690.990.220.720.020.400.21
Accounts Payable2.033.112.331.350.440.330.370.570.96
Income Tax Payable----0.000.000.00--
Other Current Liabilities6.818.523.981.070.591.241.112.533.96
Total Current Liabilities10.3317.878.003.411.252.291.503.505.13
Long Term Debt2.363.004.611.671.900.060.440.000.13
Provision for Risks Charges0.000.000.000.000.000.000.000.00-
Deferred Tax Liabilities-0.16-0.000.000.000.00--
Other Liabilities0.305.005.000.000.002.863.570.000.00
Total Liabilities13.0026.0417.615.083.165.205.513.505.26
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value2.4137.836.000.000.000.000.000.000.00
Common Equity4.82-17.79-5.11-0.987.315.74-3.71-2.72-4.99
Total Shareholders Equity7.2220.040.89-0.987.315.74-3.71-2.72-4.99
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7.2220.040.89-0.987.315.74-3.71-2.72-4.99
Total Liabilities & Stockholders Equity20.2246.0818.514.1010.4710.951.800.780.27
Book Value Per Share40.37-22,874.39-11,802.14-9,252.2970,599.3868,636.52-87,577.64-65,087.91-129,477.34
Tangible Book Value Per Share-20.00-34,645.35-34,847.34-9,252.2969,323.7567,501.61-88,924.25-65,369.64-129,900.84
Full-Time Employees424230151210521
Price to Book Ratio0.09-0.218.964.015.435.05-9.10-23.79-4.50
Return on Assets-17.80-23.97-71.07-149.52-62.16-131.01-168.50-589.42-254.11
Return on Equity-59.42-73.95--343.99-101.96-822.59---
Return on Invested Capital-61.88-33.59-146.00-1,573.28-72.24-143.88---
Quick Ratio0.250.060.120.104.804.490.960.200.03
Current Ratio0.270.070.160.185.034.611.030.210.05

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-5.29-23.32-9.26-8.03-10.89-6.65-8.35-2.17-3.08
Depreciation0.560.680.920.200.310.170.030.030.01
Other Funds (Non Cash)0.6617.313.342.612.734.064.380.562.46
Funds from Operations-4.06-5.33-5.00-5.23-7.86-2.42-3.93-1.58-0.61
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.71-1.682.020.471.25-3.61-0.852.95-0.04
Income Taxes Payable--0.00-0.000.00-0.000.000.00-
Cash from Operating Activities-4.77-7.01-2.98-4.76-6.60-6.03-4.781.37-0.65
Capital Expenditures-0.04-0.04-0.18-0.44-0.01-0.45-0.09-0.11-0.02
Net Assets From Acquisitions-2.91-2.700.47-2.040.000.000.000.000.00
Sale of Fixed Assets and Businesses0.020.000.080.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.00-0.01-0.07-1.70-0.100.000.00
Purchase of Investments0.000.000.00-0.01-0.07-1.70-0.100.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-2.93-2.750.36-2.49-0.08-2.15-0.19-0.11-0.02
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock13.1412.322.715.730.294.0211.480.000.08
Repurchase of Common Pref Stock0.00-4.000.000.000.000.000.000.000.00
Sale of Common Pref Stock13.1416.322.715.730.294.0211.480.000.08
Proceedsfrom Stock Options5.9615.211.815.700.293.6511.480.000.08
Issuance or Reduction of Debt, Net-0.23-1.220.411.660.80-0.252.35-0.230.78
Change in Long Term Debt-0.23-1.220.411.660.80-0.252.35-0.230.78
Issuance of Long Term Debt0.000.001.343.160.800.003.160.000.90
Reduction of Long Term Debt-0.23-1.22-0.93-1.500.00-0.25-0.81-0.23-0.11
Net Financing Active Other Cash Flow-2.020.000.000.000.000.000.000.000.00
Other Financing Activities Uses-2.020.000.000.000.000.000.000.000.00
Cash from Financing Activities10.8811.103.127.391.093.7713.82-0.230.86
Net Change in Cash3.181.340.500.14-5.59-4.418.861.030.19
Free Cash Flow-4.81-7.06-3.16-5.20-6.61-6.45-4.821.31-0.67
Preferred Dividends (Cash Flow)----0.000.000.000.000.00
Price to Free Cash Flow-------25.72-
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments3.734.902.080.360.550.84
Short Term Receivables0.260.250.220.270.240.17
Inventories0.250.220.230.190.210.22
Other Current Assets0.360.360.240.310.400.34
Total Current Assets4.605.732.761.141.401.57
Net Property, Plant & Equipment2.982.451.672.502.592.67
Total Investments and Advances2.472.472.473.083.110.71
Intangible Assets10.617.897.207.317.4126.79
Other Assets0.000.000.000.000.000.00
Total Assets25.8324.6620.2218.8319.3231.74
Short Term Debt Incl. Current Port. of LT Debt1.531.511.481.304.035.63
Accounts Payable1.601.672.032.392.234.79
Other Current Liabilities3.383.176.815.566.218.31
Total Current Liabilities6.526.3610.339.2412.4618.72
Long Term Debt2.392.902.362.943.103.21
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.06-----
Other Liabilities0.380.380.300.801.122.50
Total Liabilities9.349.6313.0012.9816.6924.43
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.400.402.418.8810.1234.35
Common Equity16.0914.624.82-3.03-7.49-27.04
Total Shareholders Equity16.4915.027.225.852.637.31
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity16.4915.027.225.852.637.31
Total Liabilities & Stockholders Equity25.8324.6620.2218.8319.3231.74
Book Value Per Share28.0535.6540.37-89.34-13,025.15-17,392.86
Tangible Book Value Per Share9.5516.42-20.00-304.97-25,918.81-34,625.27
Full-Time Employees--42---
Price to Book Ratio0.090.310.37-1.36-0.03-0.06
Return on Assets-26.06-35.39-65.53-149.96-138.51-99.49
Return on Equity-61.53-89.36-218.76-922.88-1,294.96-679.99
Return on Invested Capital4.71-30.9114.73-30.10-65.44-165.35
Quick Ratio0.670.870.250.100.100.07
Current Ratio0.710.900.270.120.110.08

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income0.89-5.542.01-2.64-5.28-17.40
Depreciation0.150.140.140.140.170.23
Other Funds (Non Cash)-2.113.93-1.720.563.6414.83
Funds from Operations-1.08-1.460.42-1.94-1.48-2.34
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.02-0.45-0.400.17-0.24-1.21
Cash from Operating Activities-1.10-1.920.03-1.78-1.72-3.55
Capital Expenditures0.19-0.21-0.01-0.01-0.01-0.01
Net Assets From Acquisitions-0.210.00-2.700.00-0.010.00
Sale of Fixed Assets and Businesses0.020.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.00-0.21-2.71-0.01-0.02-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.007.094.371.671.524.75
Repurchase of Common Pref Stock0.000.000.000.000.00-4.00
Sale of Common Pref Stock0.007.094.371.671.528.75
Proceedsfrom Stock Options0.000.004.311.650.508.75
Issuance or Reduction of Debt, Net-0.07-0.120.03-0.08-0.08-1.09
Change in Long Term Debt-0.07-0.120.03-0.08-0.08-1.09
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.07-0.120.03-0.08-0.08-1.09
Net Financing Active Other Cash Flow0.00-2.020.000.000.000.00
Other Financing Activities Uses0.00-2.020.000.000.000.00
Cash from Financing Activities-0.074.954.401.591.443.66
Net Change in Cash-1.172.831.72-0.19-0.290.10
Free Cash Flow-0.91-2.130.01-1.78-1.73-3.56

Revenue breakdown

Revenue From External Customers2024: 6.53M 2025: 6.84M
United States2024: 6.53M 2025: 6.84M
Consolidation, Policy2024: -29.00K 2025: -27.00K
Fertility Clinic Services2024: 6.45M 2025: 6.72M
INVOcell Device2024: 110.57K 2025: 147.19K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.68%0.0M1.1M532.90K
2026-10-150.59%0.0M1.1M532.10K
2026-09-301.18%0.0M1.1M548.48K
2026-09-154.58%0.0M1.1M1.06M
2026-08-3116.71%0.1M0.6M1.05M
2026-08-1410.38%0.1M0.6M594.07K
2026-07-3110.33%0.1M0.6M593.81K
2026-07-1514.70%0.1M0.4M599.81K
2026-06-3042.95%0.2M0.4M578.22K
2026-06-157.60%0.0M0.4M71.43K
2026-05-295.18%0.0M0.4M62.66K
2026-05-157.64%0.0M0.4M21.86K
2026-04-306.52%0.0M0.4M23.62K
2026-04-155.94%0.0M0.4M360.42K
2026-03-315.68%0.0M0.3M360.02K
2026-03-134.82%0.0M0.3M357.46K
2026-02-277.69%0.0M0.3M365.16K
2026-02-134.11%0.0M0.3M355.16K
2026-01-3015.08%0.0M0.1M353.84K
2026-01-151.75%0.0M0.1M48.35K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-048-KCurrent report2026-10-30SEC
2026-10-09SCHEDULE 13G/ASEC
2026-08-28S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-288-KCurrent report2026-08-28SEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-07424B3SEC
2026-08-07SCHEDULE 13GSEC
2026-08-04EFFECTEffectiveness filing by commission orderSEC
2026-07-24S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-07-248-KCurrent report2026-07-23SEC
2026-06-258-KCurrent report2026-06-23SEC
2026-06-23DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-23SEC
2026-06-228-KCurrent report2026-06-22SEC
2026-06-2210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-06-168-KCurrent report2026-06-16SEC
2026-06-12PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-12SEC
2026-06-1210-K/A2025-12-31SEC
2026-06-028-KCurrent report2026-06-02SEC
2026-06-0210-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-06-028-KCurrent report2026-06-01SEC
2026-05-18NT 10-Q2026-03-31SEC
2026-05-15SCHEDULE 13G/ASEC
2026-04-298-KCurrent report2026-04-23SEC
2026-04-01NT 10-K2025-12-31SEC
2026-04-01SCHEDULE 13GSEC
2026-03-318-KCurrent report2026-03-25SEC
2026-02-248-KCurrent report2026-02-18SEC
2026-02-17SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120061
2025-110000

Institutional holders

Manager% owned
Virtu Financial LLC3.54%
Scientech Research LLC1.81%
Essex LLC0.96%
StoneX Group Inc.0.81%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.64%
Tower Research Capital LLC0.46%
COMMONWEALTH EQUITY SERVICES, LLC0.27%
UBS Group AG0.06%
SBI Securities Co., Ltd.0.00%
HUNTINGTON NATIONAL BANK0.00%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.37%
Blackstone Alternative Multi-Strategy Fund-0.02%

OakChart. IVF. Cached 15 minutes.

Some panels did not load: ratings.